Effect of Teriflunomide Treatment on Microglial Activation in an MS Patient Cohort at Risk of Progression
Active, not recruitingOBSERVATIONAL
Enrollment
26
Participants
Timeline
Start Date
December 1, 2017
Primary Completion Date
June 30, 2027
Study Completion Date
December 31, 2027
Conditions
Multiple Sclerosis
Trial Locations (1)
20520
Turku PET Centre, Turku
All Listed Sponsors
lead
Turku University Hospital
OTHER_GOV
NCT03368677 - Effect of Teriflunomide Treatment on Microglial Activation in an MS Patient Cohort at Risk of Progression | Biotech Hunter | Biotech Hunter